Literature DB >> 22777295

Prediction of the vitreal half-life of small molecular drug-like compounds.

Heidi Kidron1, Eva M Del Amo, Kati-Sisko Vellonen, Arto Urtti.   

Abstract

PURPOSE: To build a fast, user-friendly computational model to predict the intravitreal half-lives of drug-like compounds.
METHODS: We used multivariate analysis to build intravitreal half-life models using two data sets, one with experimental data derived from both pigmented and albino rabbits and another including only data from experiments with albino rabbits.
RESULTS: The final models had a Q(2) value of 0.65 and 0.75 for the mixed and albino rabbit models, respectively. The models performed well in predicting the intravitreal half-life of an external test set. In addition, the models are physiologically interpretable, containing mainly hydrogen bonding and lipophilicity descriptors.
CONCLUSION: The developed models enable reliable predictions of intravitreal half-lives for use in the early drug development stages, without the need for prior experimental data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777295     DOI: 10.1007/s11095-012-0822-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  50 in total

1.  Pharmacokinetics of intravitreal vancomycin in normal and infected rabbit eyes.

Authors:  R M Coco; M I López; J C Pastor; M J Nozal
Journal:  J Ocul Pharmacol Ther       Date:  1998-12       Impact factor: 2.671

2.  Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique.

Authors:  P M Hughes; R Krishnamoorthy; A K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  1996       Impact factor: 2.671

3.  Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats.

Authors:  H M Siefert; C Kohlsdorfer; W Steinke; A Witt
Journal:  J Antimicrob Chemother       Date:  1999-05       Impact factor: 5.790

4.  Vitreal elimination kinetics of large molecular weight FITC-labeled dextrans in albino rabbits using a novel microsampling technique.

Authors:  C S Dias; A K Mitra
Journal:  J Pharm Sci       Date:  2000-05       Impact factor: 3.534

5.  Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.

Authors:  W Liu; Q F Liu; R Perkins; G Drusano; A Louie; A Madu; U Mian; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Netilmicin: new aminoglycoside effective against bacterial endophthalmitis.

Authors:  H Sloane; G A Peyman; M Raichand; S West
Journal:  Can J Ophthalmol       Date:  1981-01       Impact factor: 1.882

7.  Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model.

Authors:  S Zeng; C Hu; H Wei; Y Lu; Y Zhang; J Yang; G Yun; W Zou; B Song
Journal:  Ophthalmology       Date:  1993-11       Impact factor: 12.079

8.  Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection.

Authors:  H W Kwak; D J D'Amico
Journal:  Arch Ophthalmol       Date:  1992-02

9.  Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits.

Authors:  M Barza; E Lynch; J L Baum
Journal:  Arch Ophthalmol       Date:  1993-01

10.  The intravitreal use of carbenicillin (Geopen) for treatment od pseudomonas endophthalmitis.

Authors:  A G Schenk; G A Peyman; J T Paque
Journal:  Acta Ophthalmol (Copenh)       Date:  1974
View more
  2 in total

Review 1.  Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation.

Authors:  Felipe M González-Fernández; Annalisa Bianchera; Paolo Gasco; Sara Nicoli; Silvia Pescina
Journal:  Pharmaceutics       Date:  2021-03-26       Impact factor: 6.321

2.  A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection.

Authors:  Haixing Yang; Wenjuan Zhang; Chao Huang; Wei Zhou; Yao Yao; Zhenzhong Wang; Yan Li; Wei Xiao; Yonghua Wang
Journal:  BMC Complement Altern Med       Date:  2014-11-04       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.